Formoterol Fumarate Dihydrate Inhalation Solution Market to Grow at 3.5% CAGR by 2032 According to a newly published market research report by 24LifeSciences, global Formoterol Fumarate Dihydrate Inhalation Solution market was valued at USD 390 million in 2024 and is projected to reach USD 494 million by 2031, growing at a compound annual growth rate (CAGR) of 3.5% during the forecast period 2025–2031. Formoterol Fumarate Dihydrate Inhalation Solution is a long-acting bronchodilator used to treat respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD). As a beta-2 adrenergic agonist, it effectively opens the airways in the lungs, making breathing easier for patients. This medication is typically administered using an inhaler or nebulizer and is intended for chronic symptom management rather than immediate relief of acute respiratory symptoms. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/5052/formoterol-fumar